In briefBMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g6244 (Published 15 October 2014) Cite this as: BMJ 2014;349:g6244
New advice on cancer prevention: The International Agency for Research on Cancer’s new code on fighting cancer recommends 12 lifestyle measures to boost cancer prevention.1 These include avoiding tobacco, alcohol, and excessive sun exposure; maintaining a healthy body weight; and being physically active. It also recommends screening for bowel, breast, and cervical cancer; vaccination against human papillomavirus; breast feeding; and limiting the use of hormone replacement therapy. It also advises reducing levels of radon radiation in homes where this may be high.
GMC expects openness and honesty among doctors: Healthcare professionals must be open and honest with patients when things go wrong, says the General Medical Council and eight other UK regulators in a joint statement.2 The GMC and the Nursing and Midwifery Council are to consult on joint guidance on candour for doctors, nurses, and midwives.
GPs need software tools to aid lung cancer diagnosis: An analysis of 20 142 cases of lung cancer recorded by 444 UK general practices between 2000 and 2013 found that 25% of the patients died within three months of diagnosis, classified as “early” deaths.3 The odds of an early death were lower among patients who had undergone chest radiography in primary care but rose with the number of GP consultations they had had. GPs see about one patient a year with lung cancer, and they need assessment tools and prompts to aid diagnosis, said an editorialist.4
More QOF points for managing dementia patients: NHS Employers and the BMA’s General Practitioners Committee have agreed minor changes to the Quality and Outcomes Framework (QOF) for 2015-16.5 There will be extra points for managing atrial fibrillation and for planning and reviewing the care of patients with dementia, which replace 36 points previously assigned to chronic kidney disease and coronary heart disease. QOF overall remains the same at 559 points.
Petition for clearer warnings on varenicline: Five US non-profit organisations have submitted a citizen’s petition asking the Food and Drug Administration to require the current boxed warning on the product label for varenicline (marketed as Chantix and Champix) to clearly describe four related psychiatric adverse events: suicidal behaviour, aggression or violence, psychosis, and depression.6 They are also calling for restrictions against the use of varenicline by people in sensitive and hazardous occupations.
Cite this as: BMJ 2014;349:g6244